Catalyst Wire Dossier Catalyst Wire Dossier

PROMUS Element Everolimus-Eluting Coronary Stent System

everolimus-eluting coronary stent system · Boston Scientific
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PROMUS Element Everolimus-Eluting Coronary Stent System, covering 2012-03-07 to 2017-02-02. Get the full timeline:

Most recent: Clinical Trial Update: PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study

See pricing